Literature DB >> 11929768

Coronary no-reflow is caused by shedding of active tissue factor from dissected atherosclerotic plaque.

Diana Bonderman1, Alexander Teml, Johannes Jakowitsch, Christopher Adlbrecht, Mariann Gyöngyösi, Wolfgang Sperker, Harald Lass, Wilhelm Mosgoeller, Dietmar H Glogar, Peter Probst, Gerald Maurer, Yale Nemerson, Irene M Lang.   

Abstract

Defined angiographically, no-reflow (NR) manifests as an acute reduction in coronary flow in the absence of epicardial vessel obstruction. One candidate protein to cause coronary NR is tissue factor (TF), which is abundant in atherosclerotic plaque and a cofactor for activated plasma coagulation factor VII. Scrapings from atherosclerotic carotid arteries contained TF activity (corresponding to 33.03 +/- 13.00 pg/cm(2) luminal plaque surface). Active TF was sedimented, indicating that TF was associated with membranes. Coronary blood was drawn from 6 patients undergoing coronary interventions with the distal protection device PercuSurge GuardWire (Traatek, Miami, FL). Fine particulate material that was recovered from coronary blood showed TF activity (corresponding to 91.1 +/- 62.16 pg/mL authentic TF). To examine the role of TF in acute coronary NR, blood was drawn via a catheter from coronary vessels in 13 patients during NR and after restoration of flow. Mean TF antigen levels were elevated during NR (194.3 +/- 142.8 pg/mL) as compared with levels after flow restoration (73.27 +/- 31.90 pg/mL; P =.02). To dissect the effects of particulate material and purified TF on flow, selective intracoronary injection of atherosclerotic material or purified relipidated TF was performed in a porcine model. TF induced NR in the model, thus strengthening the concept that TF is causal, not just a bystander to atherosclerotic plaque material. The data suggest that active TF is released from dissected coronary atherosclerotic plaque and is one of the factors causing the NR phenomenon. Thus, blood-borne TF in the coronary circulation is a major determinant of flow.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11929768     DOI: 10.1182/blood.v99.8.2794

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  32 in total

1.  Prothrombotic markers and early spontaneous recanalization in ST-segment elevation myocardial infarction.

Authors:  Marie-Geneviève Huisse; Emilie Lanoy; Didier Tcheche; Laurent J Feldman; Annie Bezeaud; Eduardo Anglès-Cano; Murielle Mary-Krause; Dominique de Prost; Marie-Claude Guillin; P Gabriel Steg
Journal:  Thromb Haemost       Date:  2007-08       Impact factor: 5.249

2.  Determination of surface tissue factor thresholds that trigger coagulation at venous and arterial shear rates: amplification of 100 fM circulating tissue factor requires flow.

Authors:  Uzoma M Okorie; William S Denney; Manash S Chatterjee; Keith B Neeves; Scott L Diamond
Journal:  Blood       Date:  2008-01-18       Impact factor: 22.113

3.  Vascular endothelial tissue factor pathway inhibitor kinetics in culture following exposure to DX-9065a--a selective and direct factor Xa inhibitor.

Authors:  Richard C Becker; John H Alexander; Youfu Li; Thomas Robertson; Satoshi Kunitada; Frederick A Spencer; Hongqiu Yang; Robert A Harrington
Journal:  J Thromb Thrombolysis       Date:  2004-12       Impact factor: 2.300

Review 4.  Targeting angiogenesis to restore the microcirculation after reperfused MI.

Authors:  Anja M van der Laan; Jan J Piek; Niels van Royen
Journal:  Nat Rev Cardiol       Date:  2009-06-16       Impact factor: 32.419

Review 5.  Microparticles in hemostasis and thrombosis.

Authors:  A Phillip Owens; Nigel Mackman
Journal:  Circ Res       Date:  2011-05-13       Impact factor: 17.367

Review 6.  Microparticles: new light shed on the understanding of venous thromboembolism.

Authors:  Lin Zhou; Xiao-long Qi; Ming-xin Xu; Yu Mao; Ming-lin Liu; Hao-ming Song
Journal:  Acta Pharmacol Sin       Date:  2014-08-25       Impact factor: 6.150

7.  Microparticles of human atherosclerotic plaques enhance the shedding of the tumor necrosis factor-alpha converting enzyme/ADAM17 substrates, tumor necrosis factor and tumor necrosis factor receptor-1.

Authors:  Matthias Canault; Aurélie S Leroyer; Franck Peiretti; Guy Lesèche; Alain Tedgui; Bernadette Bonardo; Marie-Christine Alessi; Chantal M Boulanger; Gilles Nalbone
Journal:  Am J Pathol       Date:  2007-09-14       Impact factor: 4.307

Review 8.  Pharmacologic reperfusion therapy for acute myocardial infarction.

Authors:  Harry C Lowe; Briain D Mac Neill; Frans Van de Werf; Ik-Kyung Jang
Journal:  J Thromb Thrombolysis       Date:  2002-12       Impact factor: 2.300

Review 9.  Role of tissue factor in atherothrombosis.

Authors:  A Phillip Owens; Nigel Mackman
Journal:  Curr Atheroscler Rep       Date:  2012-10       Impact factor: 5.113

10.  Molecular and cellular mechanisms of the thrombotic complications of atherosclerosis.

Authors:  Peter Libby
Journal:  J Lipid Res       Date:  2008-12-18       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.